FidoCure is a brand dedicated to transforming canine cancer treatment through personalized medicine. With a focus on precision medicine, FidoCure offers an AI-enabled platform that utilizes genomic testing to determine the best course of action for your dog's cancer therapy. Unlike standard chemo and radiation, FidoCure's approach identifies possible cancer-causing mutations and suggests targeted therapy to precisely attack the cancer cells.

This innovative approach has been supported by their extensive canine cancer study, which has been peer-reviewed and published. FidoCure has sequenced, treated, and collected data from thousands of dogs, resulting in the largest proprietary cancer data set in the world. Their mission is to make effective canine cancer treatment accessible and to improve patient outcomes.

With FidoCure, there is hope for a brighter prognosis and a chance to extend the lives of our beloved dogs